ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,296, issued on Nov. 18, was assigned to HiberCell Inc. (New York).
"Perk inhibiting compounds" was invented by Mark J. Mulvihill (New York), An-Hu Li (New York) and Matthew David Surman (Albany, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds, compositions, and methods useful for inhibiting PERK and for treating related conditions, diseases, and disorders. PERK-inhibiting compounds of Formula (I) having the following structure:are described herein. Also described herein are pharmaceutical compositions containing a compound of Formula (I) in one or more pharmaceutically acceptable carriers, diluents, or excipients, a...